A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (SHARP)

Clinical Trial ID NCT00105443

PubWeight™ 63.65‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00105443

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008 54.30
2 MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009 6.13
3 Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis 2014 2.07
4 Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update. Hepatol Res 2012 1.24
5 Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies. Hepatology 2013 0.86
6 Targeting the tumor stroma in hepatocellular carcinoma. World J Hepatol 2015 0.86
7 Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma. Br J Cancer 2011 0.83
8 Clinical guideline SEOM: hepatocellular carcinoma. Clin Transl Oncol 2015 0.78
9 Accomplishments in 2008 in the management of hepatobiliary cancers. Gastrointest Cancer Res 2009 0.76
Next 100